Details.
A minimally invasive mitral valve replacement procedure for high surgical risk patients with symptomatic deterioration after tissue mitral valve replacement. The procedure may use access through the blood vessels of the groin or through the chest, and includes evaluation with cardiac CT and echocardiography, trans-septal valve deployment, hospital monitoring, and a comprehensive echocardiogram within 24 hours after the procedure.